Systemic steroids in severe sepsis and septic shock

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 2, 2012, Pages 133-139

  Patel, Gourang P ^a   Balk, Robert A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenal function; Corticosteroid; Septic shock; Severe sepsis

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; ETOMIDATE; FLUCONAZOLE; FLUDROCORTISONE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INSULIN; KETOCONAZOLE; LEVOTHYROXINE; METHYLPREDNISOLONE; NORADRENALIN; PLACEBO; PREDNISOLONE; STEROID; VASOPRESSIN;

ADRENAL FUNCTION; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LOW DRUG DOSE; MORTALITY; MUSCLE WEAKNESS; NONHUMAN; PATHOPHYSIOLOGY; POLYMYONEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY INFECTION; SEPSIS; SEPTIC SHOCK; STEROID THERAPY; SUPERINFECTION; TREATMENT DURATION; WOUND HEALING;

BLOOD PRESSURE; CHICAGO; CLINICAL TRIALS AS TOPIC; GLUCOCORTICOIDS; HUMANS; INCIDENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEPSIS; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 84855986635     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201011-1897CI     Document Type: Review

References (52)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310. (Pubitemid 32641789)
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554. (Pubitemid 36437931)
3. Russell JA. Management of sepsis. N Engl J Med 2006;355:699-713.
4. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007;35:1244-1250. (Pubitemid 46642649)
5. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Fuisson C, Beale R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
6. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009;135:181-193.
7. Moran JL, Graham PL, Rockliff S, Bersten AD. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care 2010;14:R134.
8. Annane D. Corticosteroids for sepsis: registry versus Cochrane systematic review! Crit Care 2010;14:185.
9. Lipiner-Friedman D, Sprung CL, Laterre PF, Weiss Y, Goodman SV, Vogeser M, Briegel J, Keh D, Singer M, Moreno R, et al. Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 2007;35:1012-1018. (Pubitemid 46598949)
10. Morel J, Venet C, Donati Y, Charier D, Liotier J, Frere-Meunier D, Guyomarc'h S, Diconne E, Bertrand JC, Souweine B, et al. Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy. Intensive Care Med 2006;32:1184-1190. (Pubitemid 44232413)
11. Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Voudou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006;174:1319-1326. (Pubitemid 44913033)
12. Dellinger RP. Steroid therapy of septic shock: the decision is in the eye of the beholder. Crit Care Med 2008;36:1987-1989.
13. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004;141:47-56.
14. Keh D, Sprung CL. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit Care Med 2004;32:S527-S533. (Pubitemid 39489025)
15. Carlet J. From mega to more reasonable doses of corticosteroids: a decade to recreate hope. Crit Care Med 1999;27:672-674. (Pubitemid 29218187)
16. Matot I, Sprung CL. Corticosteroids in septic shock: resurrection of the last rites? Crit Care Med 1998;26:627-629.
17. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ Jr. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-1439.
18. Mesotten D, Vanhorebeek I, Van den Berghe G. The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab 2008;4:496-505.
19. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139.
20. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
21. Hesch RD, Husch M, Kodding R, Hoffken B, Meyer T. Treatment of dopamine-dependent shock with triiodothyronine. Endocr Res Commun 1981;8:229-237. (Pubitemid 12148816)
22. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937-1949.
23. Russell JA, Walley KR, Gordon AC, Cooper DJ, Herbert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009;37:811-818.
24. Arabi YM, Al-Dorzi HM. Relative adrenal insufficiency in patients with chronic liver disease: what do we know and how is it relevant in critical care medicine. Clin Pulm Med 2010;17:232-238.
25. Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001;27:1584-1591. (Pubitemid 33027954)
26. Hamrahian AH, Oseni TS, Arafah BM. Measurement of serum free cortisol in critically ill patients. N Engl J Med 2004;350:1629-1638. (Pubitemid 38501164)
27. Arafah B. Review: hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 2006;91:3725-3745. (Pubitemid 44536835)
28. Jabre P, Combes X, Lapostolle F, Dhaouadi M, Ricard-Hibon A, Vivien B, Bertrand L, Beltramini A, Gamand P, Albizzati S, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomized controlled trial. Lancet 2009;374:293-300.
29. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisones on mortality in patients with septic shock. JAMA 2002;288:862-871.
30. Salgado DR, Verdeal JCR, Rocco JR. Adrenal function testing in patients with septic shock. Crit Care 2006;10:R149.
31. Siraux V, De Backer D, Yalavatti G, Melot C, Gervy C, Mockel J, Vincent JL. Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests. Crit Care Med 2005;33:2479-2486.
32. Sprung CL, Goodman S, Weiss YG. Steroid therapy of septic shock. Crit Care Clin 2009;25:825-834.
33. Marik PE, Kiminyo K, Zaloga GP. Adrenal insufficiency in critically ill patients with human immunodeficiency virus. Crit Care Med 2002;30:1267-1273. (Pubitemid 34620970)
34. Sessler CN. Steroids for septic shock: back from the dead? (Con). Chest 2003;123:482S-489S. (Pubitemid 36549818)
35. Balk RA. Steroids for septic shock: back from the dead? (Pro). Chest 2003;123:490S-499S. (Pubitemid 36549819)
36. McGee S, Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med 2008;168:1034-1046. (Pubitemid 351749220)
37. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976;184:333-339.
38. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-658. (Pubitemid 17138189)
39. Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317:659-665.
40. Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 1984;311:1137-1143. (Pubitemid 14012580)
41. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-650. (Pubitemid 28201409)
42. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Hevduck M, et al. Stess doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723-732. (Pubitemid 29218204)
43. Yildiz O, Doganay M, Aygen B, Guven M, Kelestimur S, Tutuu A. Physiological-dose steroid therapy in sepsis. Crit Care 2002;6:251-258.
44. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA 2000;283:1038-1045. (Pubitemid 30112218)
45. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al. Surviving sepsis campaign guidelines for severe sepsis and septic shock. Crit Care Med 2004;32:858-873. (Pubitemid 38344143)
46. Oppert M, Schindler R, Husung C, Offermann K, Graf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005;33:2457-2464. (Pubitemid 41682095)
47. Beale R, Janes JM, Brunkhorst FM, Dobb G, Levy MM, Martin GS, Ramsay G, Silva E, Sprung CL, Vallet B, et al. Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Crit Care 2010;14:R102.
48. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss Y, Benbenishty J, Kalenka A, Forst H, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-124.
49. Cuthbertson BH, Sprung CL, Annane D, Chevret S, Garfield M, Goodman S, Laterre PF, Vincent JL, Freivogel K, Rhinehart K, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009;35:1868-1876.
50. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009;301:2362-2375.
51. The COIITSS Study Investigators. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010;303:341-348.
52. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655.